Eighteen surgical patients were studied to determine the effect of anesthesia (general or spinal) and surgery on serum and urinary colony-stimulating factor(s) (CSF). CSF is a leukopoietin that stimulates proliferation of macrophages and granulocytes from bone marrow precursor cells. CSF was assayed
Granulocyte—macrophage colony-stimulating factor inhibits tumour growth
✍ Scribed by A. D. K. Hill; Professor H. P. Redmond; O. M. Austin; P. A. Grace; D. Bouchier-Hayes
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 421 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
✦ Synopsis
G ranu locyte-macro phage colony-stimulating factor in hi bits tumour growth
The efSect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on murine antitumour responses was examined. Sixty mice received Lewis lung carcinoma implants and were then randomized to receive GM-CSF 1 pglday, GM-CSF0.5 pglday or saline for I0 days and studied with regard to tumour volume, carcass weight and food intake. Macrophage antitumour mechanisms including oxygen free radical production and nitric oxide release were studied in peritoneal macrophages after co-culture with GM-CSF in vitro and in vivo. GM-CSF 1 pglday decreased tumour growth after 5 days (mean(s.e.m.) 0.62(0.14) versus 1.24(0.19) ern3, P = 0.01 7). GM-CSF upregulated macrophage antitumour mechanisms by enhancing the in vivo production of superoxide radicals (mean( s.e.m. ) 0-69( 0.06) versus 0*45(0.10) nmol, P < 0.05) andnitric oxide (mean(s.e.m.) 48(3) versus 24(4) pmol, P < 0.01). GM-CSF functions through the enhancement of macrophage tumoricidal activity, suggesting a therapeutic potential for this cytokine in the tumour-bearing host.
📜 SIMILAR VOLUMES
## Abstract Granulocyte‐macrophage colony stimulating factor (GM‐CSF) has immunoregulatory and antiviral effects, and may thus be promising for the treatment of chronic hepatitis B. Using woodchuck hepatitis virus (WHV)‐infected woodchuck as an animal model to test the efficacy and safety of GM‐CSF
## Abstract We previously established 2 lung cancer cell lines, OKa‐C‐1 and MI‐4, which constitutively produce an abundant dose of granulocyte‐colony stimulating factor (G‐CSF) and granulocyte macrophage‐colony stimulating factor (GM‐CSF). Many other cases with G‐CSF or GM‐CSF producing tumors have
## Abstract Sweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim, a drug that causes increased neutrophil proliferation and differentiation. This complication has not previously been reported during treatment with sargramostim